Biomechanical forces promote embryonic haematopoiesis L Adamo, O Naveiras, PL Wenzel, S McKinney-Freeman, PJ Mack, ... Nature 459 (7250), 1131-1135, 2009 | 590 | 2009 |
Reappraising the role of inflammation in heart failure L Adamo, C Rocha-Resende, SD Prabhu, DL Mann Nature Reviews Cardiology 17 (5), 269-285, 2020 | 503 | 2020 |
Microfluidics-based assessment of cell deformability A Adamo, A Sharei, L Adamo, BK Lee, S Mao, KF Jensen Analytical chemistry 84 (15), 6438-6443, 2012 | 220 | 2012 |
Abnormal global longitudinal strain predicts future deterioration of left ventricular function in heart failure patients with a recovered left ventricular ejection fraction L Adamo, A Perry, E Novak, M Makan, BR Lindman, DL Mann Circulation: Heart Failure 10 (6), e003788, 2017 | 88 | 2017 |
Reverse remodeling in dilated cardiomyopathy: insights and future perspectives M Merlo, T Caiffa, M Gobbo, L Adamo, G Sinagra IJC heart & vasculature 18, 52-57, 2018 | 86 | 2018 |
Biomechanical forces promote blood development through prostaglandin E2 and the cAMP–PKA signaling axis MF Diaz, N Li, HJ Lee, L Adamo, SM Evans, HE Willey, N Arora, ... Journal of Experimental Medicine 212 (5), 665-680, 2015 | 85 | 2015 |
Directed stem cell differentiation by fluid mechanical forces L Adamo, G García-Cardeña Antioxidants & redox signaling 15 (5), 1463-1473, 2011 | 75 | 2011 |
Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury L Adamo, LJ Staloch, C Rocha-Resende, SJ Matkovich, W Jiang, ... JCI insight 3 (11), 2018 | 74 | 2018 |
Proteomic signatures of heart failure in relation to left ventricular ejection fraction L Adamo, J Yu, C Rocha-Resende, A Javaheri, RD Head, DL Mann Journal of the American College of Cardiology 76 (17), 1982-1994, 2020 | 68 | 2020 |
Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart L Adamo, C Rocha-Resende, CY Lin, S Evans, J Williams, H Dun, W Li, ... JCI insight 5 (3), 2020 | 66 | 2020 |
Pirfenidone is a cardioprotective drug: mechanisms of action and preclinical evidence A Aimo, E Cerbai, G Bartolucci, L Adamo, A Barison, GL Surdo, S Biagini, ... Pharmacological research 155, 104694, 2020 | 62 | 2020 |
Reduced apolipoprotein M and adverse outcomes across the spectrum of human heart failure JA Chirinos, L Zhao, Y Jia, C Frej, L Adamo, D Mann, SV Shewale, ... Circulation 141 (18), 1463-1476, 2020 | 54 | 2020 |
Prevalence of lactic acidaemia in patients with advanced heart failure and depressed cardiac output L Adamo, ME Nassif, E Novak, SJ LaRue, DL Mann European journal of heart failure 19 (8), 1027-1033, 2017 | 49 | 2017 |
The vascular origin of hematopoietic cells L Adamo, G García-Cardeña Developmental biology 362 (1), 1-10, 2012 | 44 | 2012 |
The emerging role of B lymphocytes in cardiovascular disease L Adamo, C Rocha-Resende, DL Mann Annual review of immunology 38, 99-121, 2020 | 42 | 2020 |
The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients L Adamo, M Nassif, A Tibrewala, E Novak, J Vader, SC Silvestry, A Itoh, ... JACC: Heart Failure 3 (4), 283-290, 2015 | 32 | 2015 |
Surgical threshold for bicuspid aortic valve aneurysm: a case for individual decision-making L Adamo, AC Braverman Heart 101 (17), 1361-1367, 2015 | 30 | 2015 |
The HeartMate risk score identifies patients with similar mortality risk across all INTERMACS profiles in a large multicenter analysis L Adamo, Y Tang, ME Nassif, E Novak, PG Jones, S LaRue, JA Spertus, ... JACC: Heart Failure 4 (12), 950-958, 2016 | 24 | 2016 |
Relationship between device acceptance and patient-reported outcomes in Left Ventricular Assist Device (LVAD) recipients C Tosto, L Adamo, H Craddock, M Di Blasi, R Girgenti, F Clemenza, ... Scientific reports 9 (1), 10778, 2019 | 23 | 2019 |
Immunomodulatory role of nonneuronal cholinergic signaling in myocardial injury C Rocha-Resende, C Weinheimer, G Bajpai, L Adamo, SJ Matkovich, ... JCI insight 4 (14), 2019 | 22 | 2019 |